GoodRx Holdings (GDRX) Other financing activities (2020 - 2023)

GoodRx Holdings has disclosed Other financing activities across 4 years of filings, most recently posting $3.7 million for Q1 2023.

• Other financing activities for Q1 2023 came in at $3.7 million, down 61.2% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.7 million (up 126.79% YoY), and the FY2024 annual result was $2.7 million, changed N/A from the prior year.
• Other financing activities came in at $3.7 million for Q1 2023 at GoodRx Holdings, up from -$17.6 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $82.3 million in Q4 2020 to a low of -$17.6 million in Q4 2022.
• The 4-year median for Other financing activities is $9.6 million (2022), against an average of $17.2 million.
• Across the five-year window, Other financing activities soared 493.62% in 2021 and sank 130.29% in 2022, its largest moves.
• GoodRx Holdings' Other financing activities stood at $82.3 million in 2020, then fell by 29.55% to $58.0 million in 2021, then tumbled by 130.29% to -$17.6 million in 2022, then jumped by 121.13% to $3.7 million in 2023.
• The last three Other financing activities figures came in at $3.7 million (Q1 2023), -$17.6 million (Q4 2022), and $3.3 million (Q3 2022), per Business Quant data.